VBI Vaccines Inc (VBIV)
0.5994
+0.01
(+1.59%)
USD |
NASDAQ |
Apr 25, 16:00
0.599
0.00 (0.00%)
After-Hours: 20:00
VBI Vaccines Cash from Investing (TTM): -0.867M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -0.867M |
September 30, 2023 | -2.149M |
June 30, 2023 | -3.336M |
March 31, 2023 | -4.363M |
December 31, 2022 | -4.344M |
September 30, 2022 | -3.502M |
June 30, 2022 | -2.627M |
March 31, 2022 | 23.20M |
December 31, 2021 | 23.16M |
September 30, 2021 | 23.23M |
June 30, 2021 | 23.46M |
March 31, 2021 | -26.42M |
December 31, 2020 | -26.00M |
September 30, 2020 | -25.65M |
June 30, 2020 | -26.04M |
March 31, 2020 | -1.91M |
December 31, 2019 | -3.673M |
September 30, 2019 | -5.861M |
June 30, 2019 | -6.857M |
March 31, 2019 | -6.874M |
December 31, 2018 | -5.993M |
September 30, 2018 | -3.672M |
June 30, 2018 | -2.194M |
March 31, 2018 | -1.328M |
December 31, 2017 | -0.579M |
Date | Value |
---|---|
September 30, 2017 | -0.626M |
June 30, 2017 | -0.789M |
March 31, 2017 | 1.367M |
December 31, 2016 | 1.50M |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | -8.748M |
March 31, 2015 | -9.544M |
December 31, 2014 | -10.36M |
September 30, 2014 | -0.7716M |
June 30, 2014 | -0.6891M |
March 31, 2014 | -1.956M |
December 31, 2013 | -4.09M |
September 30, 2013 | -4.149M |
June 30, 2013 | -4.133M |
March 31, 2013 | -2.081M |
December 31, 2012 | -0.0157M |
September 30, 2012 | 0.1434M |
June 30, 2012 | 0.059M |
March 31, 2012 | 0.0709M |
December 31, 2011 | 9.511M |
September 30, 2011 | 10.45M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-26.42M
Minimum
Mar 2021
23.46M
Maximum
Jun 2021
-2.661M
Average
-3.502M
Median
Sep 2022
Cash from Investing (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | -0.019M |
Palatin Technologies Inc | 9.293M |
iBio Inc | 8.285M |
Theriva Biologics Inc | -0.202M |
Oragenics Inc | -0.9363M |